Publications by authors named "Mariele Goebeler"

Claim this Profile
R
Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking.
Friederike Braig, Anna Brandt, Mariele Goebeler, Hans-Peter Tony, Anna-Katharina Kurze

Blood· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab.
Matthias Klinger, Christian Brandl, Gerhard Zugmaier, Youssef Hijazi, Ralf C Bargou, Mariele Goebeler

Blood· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial.
Volker Kunzmann, Manfred Smetak, Brigitte Kimmel, Karin Weigang-Koehler, Mariele Goebeler

J Immunother· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.
Norbert Gattermann, Andrea Jarisch, Rudolf Schlag, Klaus Blumenstengel, Mariele Goebeler

Eur J Haematol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.
Max S Topp, Peter Kufer, Nicola Gökbuget, Mariele Goebeler, Matthias Klinger

J Clin Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
Ludwig Fischer von Weikersthal, Andreas Schalhorn, Martina Stauch, Detlef Quietzsch, Peter A Maubach, Mariele Goebeler

Eur J Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.
Ralf Bargou, Eugen Leo, Gerhard Zugmaier, Matthias Klinger, Mariele Goebeler

Science· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, Hermann Heimpel, Andreas Hochhaus, Mariele E Goebeler

Blood· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis